Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 1/2 3Phase 1 2Phase 4 1Phase 3 1

Status

Completed 46Recruiting 15Active not recruiting 13Terminated 11Withdrawn 4Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Laryngeal Neoplasms 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Cyclophosphamide 49fludarabine 37Injections 32Gemcitabine 24Paclitaxel 23Cisplatin 21pembrolizumab 19Radiotherapy 19toripalimab 18Carboplatin 17Capecitabine 17Fluorouracil 15Oxaliplatin 13Nivolumab 12Docetaxel 12camrelizumab 11apatinib 11Temozolomide 11Cetuximab 11Bevacizumab 10Irinotecan 9Immunotherapy, Adoptive 9Drug Therapy 9Etoposide 8sintilimab 7Radiosurgery 7Peripheral Blood Stem Cell Transplantation 7Leucovorin 7Ipilimumab 7Indium 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Unknown × olaparib × Clear all
NCT02229656 2023-11-07

Olaparib and Radiotherapy in Head and Neck Cancer

The Netherlands Cancer Institute

Phase 1 Unknown
12 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms

NCT01460888 2013-08-19

ROCOCO

The Christie NHS Foundation Trust

Phase 1 Unknown
36 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡